Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

18 Feb 2016 - 20 Feb 2016
25 Feb 2016 - 26 Feb 2016

Microfluidic Silicon Probe Accurately Stains Tissue Sections

By Labmedica International staff writers
Posted on 24 Jan 2012
Print article
Image: The probe consists of a silicon microfluidic head having two microchannels. Unlike an inkjet printer cartridge, the head reaspirates the liquid that it injects on a surface. This prevents spreading and accumulation of the liquid on the surface, which can lead to overexposure (Photo courtesy of IBM).
Image: The probe consists of a silicon microfluidic head having two microchannels. Unlike an inkjet printer cartridge, the head reaspirates the liquid that it injects on a surface. This prevents spreading and accumulation of the liquid on the surface, which can lead to overexposure (Photo courtesy of IBM).
A flexible, noncontact microfluidic probe made from silicon can help pathologists to investigate critical tissue samples for disease diagnostics.

The microfluidic probe can accurately stain tissue sections at the micrometer scale. It consists of a silicon microfluidic head having two microchannels. Unlike an inkjet printer cartridge, the head reaspirates the liquid that it injects on a surface. This prevents spreading and accumulation of the liquid on the surface, which can lead to overexposure.

Specifically for tissue section analysis, the probe can deliver an antibody very locally in a selected area of a tissue section with pinpoint accuracy. Since analysis can be done on spots and lines instead of on the entire tissue section, the tissue is better preserved for additional tests, if required. In addition, only a few picoliters of liquid containing antibodies are needed for each analysis spot.

IBM (Zurich, Switzerland) scientists developed the microfluidic probe, which fits to standard workflows in conventional pathology. In addition, it is compatible with current biochemical staining systems and resistant to a broad range of chemicals. The small size of the probe also enables easy viewing of the sample from above and below by the inverted microscope commonly used in clinical laboratories.

"We have developed a proof-of-concept technology, which I hope puts pathology on a modern roadmap—benefiting from the latest developments in silicon-based microfluidics," said Govind Kaigala, a scientist at IBM Research-Zurich. He added, "This new approach will enable pathologists to stain tissue samples with micrometer precision and easily perform multiple tissue stains on limited samples."

IBM scientists will continue to test and improve the microfluidic probe and potentially begin using it in laboratory environments in the next several months. In addition, the team plans to explore specific clinical applications, possibly with partners in the field of pathology. The microfluidic probe promises to support the work of pathologists and become a tool of choice for pharmaceutical research and diagnostics involving biological specimens.

Related Links:

IBM Research, Zurich



Print article
Micromedic Technologies

Channels

Immunology

view channel
Image: Micrograph of prostatic adenocarcinoma with perineural invasion, conventional (acinar) type, the most common form of prostate cancer. Prostate biopsy, H&E stain (Photo courtesy of Nephron and Wikimedia).

Reduced PSA Screening May Delay Treatment for Earlier Onset Prostate Cancers

The recommendation against regular prostate specific antigen (PSA) screening for prostate cancer (PCa) has been in place for 2.5 years. The number of prostate needle biopsies (PNB) has been reduced and... Read more

Industry News

view channel
Image: The new CE-marked “illumigene Malaria” DNA amplification assay for detection of Plasmodium spp. DNA in human whole blood samples (Photo courtesy of Meridian Bioscience).

Collaboration Helps Accelerate Launch of New Malaria Test

The recent launch of a new in vitro diagnostic (IVD) assay, CE-marked for detection of Plasmodium spp. DNA in whole blood samples, was accomplished on an accelerated schedule via collaboration with “lean... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.